Astex awarded The Sunday Times Microsoft Tech Track 100 Research and Development Award 2004

06-Dec-2004

Astex Technology, the fragment-based drug discovery and development company, received the Research and Development Award 2004 at the Sunday Times Microsoft Tech Track 100 awards ceremony held on the 30th November. The award recognises Astex's pioneering research and development into novel drugs to treat major diseases including cancer and Alzheimer's disease. Astex has ranked as the fastest growing UK biotechnology company in the Tech Track 100 league for the past two years and is one of a select few biotechnology companies to be included in the annual Tech Track 100 since its launch in 2001.

"It is an honour to receive the special award for Research and Development 2004 and to be ranked as Britain's top biotech company for the second year in a row in this prestigious listing of Britain's fastest growing technology companies. We're extremely proud of this special recognition of our achievements which is a tribute shared by everyone in the company," stated Mr. Timothy Haines, CEO of Astex.

Other news from the department science

Most read news

More news from our other portals

Fighting cancer: latest developments and advances